کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
7623838 | 1494547 | 2015 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Probiotic Lactobacillus casei Shirota improves kidney function, inflammation and bowel movements in hospitalized patients with acute gastroenteritis - A prospective study
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
مهندسی و علوم پایه
شیمی
شیمی آنالیزی یا شیمی تجزیه
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Lactobacillus casei Shirota (LcS) is a probiotic strain typically consumed with dairy products. In this study 142 hospitalized patients with symptoms of acute gastroenteritis were included. Patients in the LcS group received twice daily 65âml of a commercial beverage containing L.âcasei Shirota. The treatment with LcS resulted in a significantly decreased daily average (â5.42 vs. â4.40) and cumulative rate of bowel movements (â32.49 vs. â26.43) and improvement of the glomerular filtration rate (after 24 hours: 41.9â±â2.8 vs. 25.9â±â4.2âml/min, pâ<â0.01). Furthermore, treatment with LcS resulted in a significant decrease of CRP on days five, six and seven. Leukocyte counts decreased in all groups, while on day three the effect was significantly higher in the LcS group receiving antibiotics. In our study, L.âcasei Shirota administration twice a day had positive effects on the reduction of bowel movements, improvement of kidney function and inflammation compared to the control group. Hence, we would suggest that additional LcS administration might be considered in those patients with acute gastroenteritis who present with high inflammation markers and/or acute impaired kidney function.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Functional Foods - Volume 17, August 2015, Pages 305-313
Journal: Journal of Functional Foods - Volume 17, August 2015, Pages 305-313
نویسندگان
Bora Akoglu, Alexander Loytved, Hannah Nuiding, Stefan Zeuzem, Dominik Faust,